Adrian Towse

Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force

Louis P. Garrison, Adrian Towse, Andrew Briggs et al. · Value in Health · 2013 · 306 citations

Management, Performance Management, Risk Management +10

Prospective Observational Studies to Assess Comparative Effectiveness: The ISPOR Good Research Practices Task Force Report

Marc L. Berger, Nancy A Dreyer, Fred Anderson et al. · Value in Health · 2012 · 190 citations · Full text

Pharmacy, Pharmacoeconomics, Comparative Effectiveness Research +13

Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest Group

E.C. Faulkner, Lieven Annemans, L. Garrison et al. · Value in Health · 2012 · 159 citations · Full text

Health Professions, Health Services Administration, Pharmacoeconomics +15

Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement

Patricia M. Danzon, Andrew Mulcahy, Adrian Towse · Health Economics · 2013 · 154 citations · Full text

Pharmacy, Economics, Pharmaceutical Policy +17

A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]

Louis P. Garrison, Peter J. Neumann, Richard J. Willke et al. · Value in Health · 2018 · 154 citations · Full text

Pharmacy, Health Policy, Health Systems +13